French biotech company Ipsen to buy Kartos Therapeutics for $450 million

🌐 Investing.com (CY) — 2026-06-29

French biotech company Ipsen is set to acquire Kartos Therapeutics for $450 million. The deal highlights Ipsen's strategic expansion in the biopharmaceutical sector.

Markets Deals Health Ipsen Kartos Therapeutics biotech acquisition biopharmaceuticals M&A

Read original source →

PSG in talks with Leipzig to buy Ivory Coast star Diomande
Punch Nigeria — 2026-06-29
Lewandowski close to Chicago Fire transfer — Report
Punch Nigeria — 2026-06-29
New budget airline could fly you from Sydney, Melbourne and Brisbane
The Sydney Morning Herald — 2026-06-29
UK firm bombarded debt-ridden people with 5.5M texts
The Register — 2026-06-29
US-Iran war: Moody’s confident India can withstand fiscal deficit target breach
The Times of India — 2026-06-29
China imposes export controls on 40 Japanese entities as tensions with Tokyo rise
The Hindu — 2026-06-29

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

AI Summary

Related Articles

PSG in talks with Leipzig to buy Ivory Coast star Diomande

Lewandowski close to Chicago Fire transfer — Report

New budget airline could fly you from Sydney, Melbourne and Brisbane

UK firm bombarded debt-ridden people with 5.5M texts

US-Iran war: Moody’s confident India can withstand fiscal deficit target breach

China imposes export controls on 40 Japanese entities as tensions with Tokyo rise